Plasmacytomas are rare tumors, which arise from the monoclonal proliferation of malignant plasma cells. They may affect either the bony skeleton or rarely the soft tissues, the latter being referred to as extramedullary or extraosseous. We report a case of an extramedullary plasmacytoma that presented as a soft tissue mass involving the muscles of the left leg, in a patient who was previously treated for multiple myeloma. We describe the MR Imaging characteristics of the tumor and highlight the usefulness of diffusion-weighted imaging with apparent diffusion coefficient mapping.
CASE REPORT
This case is of a 77 year old male patient who was diagnosed with IgG (lambda) multiple myeloma at age 72. Following the initial diagnosis, he was treated with bortezomib and dexamethasone. After completion of treatment, he was in remission for 9 months when he developed anterior chest masses that were biopsied and found to be plasmacytomas. These masses rapidly resolved following chemotherapy with bortezomib and lenalidomide. After another period of remission lasting 2 years, he developed a posterior left thigh mass, for which he was started on carfilzonib and dexamethasone. The posterior thigh mass slowly decreased in size, but the lower leg subsequently became swollen.
An MRI of the left lower extremity was performed 22 days after presentation of the leg swelling to evaluate it. In light of the patient's comorbidities and declining renal function, gadolinium was not administered. The MRI demonstrated two large infiltrative intramuscular solid masses involving the anterolateral and posterior compartments. The masses were homogeneously T1 isointense and T2 hyperintense relative to skeletal muscle ( Fig. 1 & Fig. 2 ). The anterior compartment mass was centered in the extensor hallucis longus and extensor digitorum longus muscles, and extended laterally to involve the peroneus brevis and longus. In addition, it extended posteromedially through the interosseous membrane and involved the popliteus muscle. At this level, it abutted the posterior tibial artery and tibial nerve in the deep posterior compartment. The mass partially encased the fibula and abutted the lateral tibia, which revealed adjacent cortical scalloping. The fibular nerve distal to the fibular tunnel was completely encased by the mass. The mass measured 5.3 x 6.4 x 9.4 cm in the anteroposterior (AP), transverse and craniocaudal (CC) dimensions.
The second mass was centered in the lateral head of the gastrocnemius with similar signal characteristics. It approximated but did not encase the adjacent tibial neurovascular bundle (Fig. 3) . It measured 7.9 x 5.6 x 9.4 cm (AP x transverse x CC). The masses both showed high signal intensity on diffusion weighted imaging (DWI) and corresponding low values on apparent diffusion coefficient (ADC) maps, consistent with restricted diffusion (Fig 6 a-c) .
The ADC values of the tumor ranged from 0.88 to 1.1 as compared to ADC values of approximately 1.7 for regional normal musculature. These imaging findings suggested a differential diagnosis, including extramedullary plasmacytoma, sarcoma, lymphoma, sarcoidosis, abscess, and muscle infarction.
An ultrasound-guided core needle biopsy of the left leg posterior compartment mass showed diffuse infiltration of the skeletal muscle and fibro-connective tissue by sheets of monotonous neoplastic plasma cells (Fig 10) . By immunohistochemistry, the neoplastic plasma cells were positive for CD138, with lambda light chain restriction. There was focal weak expression of CD3, which has been reported in plasma cell neoplasms [1] .
The patient was treated with palliative radiation therapy to the left leg and Lenalidomide, to which he responded well with decreasing lower extremity swelling. In this case, clinical examination allowed sufficient assessment of therapeutic response. Hence, post-treatment MRI/ADC maps were not available.
Etiology & Demographics:
Plasmacytoma is one form of plasma cell neoplasia that results from dysregulated proliferation of plasma cells, others including multiple myeloma and monoclonal gammopathy of undetermined significance (MGUS). Plasmacytomas may arise from osseous structures (medullary) or soft tissues (extramedullary). Extramedullary plasmacytomas account for only 4% of all plasma cell tumors and the most common site of their occurrence (over 80%) is the upper aerodigestive tract. It usually occurs between the fourth and seventh decades of life, and is more common in men [2] . Cases of solitary extramedullary plasmacytomas affecting the skeletal muscles are rare, as these tumors are usually seen late in the course of relapsed myeloma patients.
Imaging descriptions of extramedullary myeloma are restricted to case reports and small case series [3, 4] .
Clinical & Imaging findings:
The clinical presentation of solitary extramedullary plasmacytoma of skeletal muscles depends on the location and size of the tumor, as well as compression and/or involvement of surrounding structures. These soft tissue masses usually appear hypo-to isointense on T1 weighted imaging and iso-to hyperintense on T2 weighted imaging in comparison to muscle, with heterogeneous enhancement [3, 5] . Large tumors may have areas of necrosis and are often associated with infiltration, destruction or encasement of adjacent structures. CT may outperform MRI in detecting subtle bone erosions [5] .
DWI is an MRI technique based on the random Brownian motion of water molecules in the region of interest. The ADC value is a measure of the magnitude of diffusion, and can be used to assess the cellularity within a region. The ADC value is generally low in highly cellular tissues as diffusion is restricted by the presence of cell membranes. Conversely, it is high in regions with less cellularity, wherein diffusion is not as restricted. Decreased ADC values are also noted with other processes that increase the viscosity of a region such as cellular damage with fragmentation, as seen in areas of infarction, or the presence of mucoid proteins, cellular debris and bacteria as within abscesses. The DWI sequences can be easily incorporated into the routine MRI protocol with little extra scanning time. Further, in cases where the use of gadolinium-based contrast material is contraindicated (as in this patient), DWI can be useful in differentiating solid from cystic lesions. This technique can provide useful information for characterizing musculoskeletal soft tissue lesions and evaluating response to treatment [6] , with longitudinal increases in tumor ADC values thought to reflect histologic necrosis and positive treatment response [7] .
Treatment & Prognosis:
Solitary extramedullary plasmacytomas may be treated by surgery alone, however this is often not feasible due to the presence of vital structures adjacent to the tumor. Combining surgery with radiotherapy seems to be the best approach for effective treatment [2] . Alkylating chemotherapy may be used when extramedullary plasmacytoma develops in the presence of a systemic. Chemotherapy or radiation therapy can be used palliatively. Autologous stem cell transplant may be performed in appropriate candidates [8] . However, even after successful therapy, patients need to be under life-long observation for relapses, which may appear even several years later [2] . The median survival time for a patient with pre-existing multiple myeloma who is newly diagnosed with extramedullary plasmacytoma is 24 months, whereas, if extramedullary plasmacytoma is present at the time of diagnosis of multiple myeloma, the median survival time is 12 months [9] . Older patients with extramedullary plasmacytoma have a poorer prognosis, with the 5-year survival decreasing from 78.9% for patients younger than 60 years to 70.5% for those over the age of 60 [10] . Extramedullary plasmacytoma relapse in soft tissues, as our patient had, is unfortunately associated with a dismal prognosis with overall survival being 5 months [11] .
Differential Diagnoses:
•
The imaging findings can be similar among these entities, which exhibit high T2 signal intensity with decreased ADC values compared to normal musculature. Higher grade sarcomas often exhibit internal signal heterogeneity due to varying degrees of spontaneous necrosis, as well as peritumoral soft tissue edema [12] . Recently sarcomas have been shown to have a higher range of ADC values, whereas intramuscular lymphoma shows more homogeneously low ADC values [13] , similar to our case (Fig 6) . Muscle infarction generally presents with edematous swelling of muscle, with geographic hypoenhancement on post-contrast imaging, unlike the solid enhancement exhibited here. Nodular sarcoidal myopathy exhibits low signal intensity centrally on T2-weighted imaging with contrast enhancement of peripheral area, described as a 'dark star appearance ' [14] . Clinical history and course might aid in distinguishing DISCUSSION sarcoidosis and abscess from neoplasm, but ultimately biopsy is necessary for definitive diagnosis.
Extramedullary plasmacytoma, although rare, must be considered in the differential diagnosis when evaluating a soft tissue mass in patients with multiple myeloma. Including Diffusion-Weighted Imaging sequences in the MRI protocol for soft tissue tumors can facilitate identification of highly cellular tumors, manifested as low signal on ADC maps, and aid in selecting tissue targets for biopsy. 
Etiology

Unknown
Incidence
4% of all plasma cell tumors Gender ratio
Male preponderance Age predilection Mainly occurs between the fourth and seventh decades of life.
Risk factors
Age between 30 to 70 years, male gender, African-American race, family history and exposure to ionizing radiation.
Treatment
Alkylating chemotherapy when seen in context of systemic disease, i.e. multiple myeloma; surgery with radiotherapy for localized disease with adjuvant chemotherapy; chemotherapy or radiation therapy can be used palliatively.
Prognosis
The median survival time for a patient with multiple myeloma newly diagnosed with extramedullary plasmacytoma is 24 months. If extramedullary plasmacytoma is present at the time of diagnosis of multiple myeloma, the median survival time is 12 months. Extramedullary plasmacytoma relapse in the soft tissues is associated with a dismal prognosis with overall survival of 5 months. Imaging findings Appears hypo-to isointense on T1 weighted imaging and iso-to hyperintense on T2 weighted imaging in comparison to muscle. ADC values less than that of normal musculature 
